Fusion Pharmaceuticals Inc. Debt Instrument, Unamortized Discount
Fusion Pharmaceuticals Inc. had Debt Instrument, Unamortized Discount of $891.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentUnamortizedDiscount · last filed 2024-05-07
- 2024-03-31: Debt Instrument, Unamortized Discount $891.00K.
- 2023-12-31: Debt Instrument, Unamortized Discount $665.00K.
- 2023-09-30: Debt Instrument, Unamortized Discount $724.00K.
- 2023-06-30: Debt Instrument, Unamortized Discount $781.00K.
| Period end | Debt Instrument, Unamortized Discount | Debt Instrument, Unamortized Discount as first filed |
|---|---|---|
| 2024-03-31 | $891.00K 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $665.00K 10-K · filed 2024-03-20 | |
| 2023-09-30 | $724.00K 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $781.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $665.00K 10-Q · filed 2024-05-07 | $835.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $887.00K 10-K · filed 2024-03-20 | |
| 2022-09-30 | $939.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $390.00K 10-Q · filed 2022-08-09 |